Clinical Trial Update: French Cohort for the Study of Non-invasive Tests of Liver Lesions in NAFLD/NASH (FreSH Cohort) [NA]

View source ↗

Summary

The FreSH Cohort study in France, evaluating non-invasive tests for liver lesions in non-alcoholic fatty liver disease (NAFLD/NASH), has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Snippet

Sponsor: University Hospital, Angers | Conditions: NAFLD | NA | Status: COMPLETED